Skip to main content
Linical Co., Ltd. logo

Linical Co., Ltd. — Investor Relations & Filings

Ticker · 2183 ISIN · JP3974530002 T Professional, scientific and technical activities
Filings indexed 59 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country JP Japan
Listing T 2183

About Linical Co., Ltd.

https://www.linical.com/

Linical is a global Contract Research Organization (CRO) providing a full spectrum of drug development services to biopharmaceutical companies. The company supports clinical trials from early-stage research to large-scale, multinational studies (Phase I-IV). Its services include clinical trial strategy, consulting, monitoring, and quality control. Linical focuses on a collaborative approach to guide clients through the clinical development process, aiming to expedite timelines and achieve enrollment goals without compromising quality.

Recent filings

Filing Released Lang Actions
臨時報告書
Regulatory Filings Classification · 85% confidence The document is a Japanese ‘臨時報告書’ (extraordinary/timely disclosure) filed under the Financial Instruments and Exchange Act, akin to a Form 8-K, notifying investors of impairment losses. It does not contain full periodic financial statements like an Annual or Interim Report, nor is it an earnings release or management presentation. It is a regulatory disclosure of a material event. Therefore the correct category is the general regulatory filing fallback (RNS).
2026-05-15 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report (in this case, a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 21
2025-11-14 Japanese
半期報告書-第21期(2025/04/01-2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Linical Co., Ltd. with the Kinki Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement for the interim period ending September 30, 2025. As it is a formal, comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2026
2025-11-14 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being filed because resolutions were passed at the "第20回定時株主総会" (20th Annual General Meeting) held on June 25, 2025, pursuant to Japanese financial regulations (Financial Instruments and Exchange Act). Section 2 details the resolutions, which concern the election of directors and auditors. This content—reporting the results of a shareholder vote at an AGM—perfectly matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, the primary purpose is reporting the *results* of the vote, not providing the initial meeting materials (AGM-R) or proxy information (PSI).
2025-06-26 Japanese
内部統制報告書-第20期(2024/04/01-2025/03/31)
Governance Information Classification · 100% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the header and within the table structure. It references the legal basis as "金融商品取引法第24条の4の4第1項" (Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act), which mandates the filing of an Internal Control Report in Japan. The content details the framework, scope, criteria (using March 31, 2025, as the base date), and the conclusion that internal controls over financial reporting are effective. This directly corresponds to the requirements for an Internal Control Report, which is a specific type of annual disclosure in Japan, often filed alongside the 10-K equivalent or as a standalone report. Given the specific Japanese regulatory context and the document's explicit content, it is classified as an Audit Report / Information (AR), as it deals with the assessment of internal controls over financial reporting, which is closely related to auditing standards, although it is not the full 10-K or a standard external audit report. However, looking at the provided definitions, 'AR' is defined as 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)'. Since this is a formal report on internal control effectiveness mandated by financial law, AR is the closest fit among the options, representing a formal assurance/control report. Revisiting the definitions: 10-K is the 'Official yearly report covering company activity and full financial performance.' This document is a component of the annual disclosure package. AR is for 'Standalone audit reports...'. While this is an internal control report, it serves a similar assurance function. Given the highly specific nature of Japanese filings, and the lack of a dedicated 'Internal Control Report' code, AR is the most appropriate category for a formal, assurance-related report on financial reporting integrity that is not the full 10-K.
2025-06-24 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act to confirm the accuracy of the contents of the Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report like an Annual Report, should be classified as Regulatory Filings (RNS). FY 2025
2025-06-24 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.